Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

20 June 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Velosulin Articles

Lilly pulls out of inhaled insulin development

17 March 2008

Pfizer announces Exubera job cuts; Wyeth may cut workforce 10%

4 February 2008

Pfizer's 1st-qtr profits tumble 17.5%

30 April 2007

Exubera shows safety and efficacy

7 February 2007

Exubera use not complicated by respiratory infections

25 September 2006

Emerging diabetes management solutions boost European market

14 August 2006

NICE says inhaled insulin "too expensive" for UK, Pfizer appeals to health professionals

24 April 2006

Novo Nordisk's recombinant Velosulin OKed in USA

27 July 1999

Showing 1-8 of 8 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
  • FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
  • Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
  • US Supreme Court says patent settlement can "sometimes" be illegal
  • Actavis and Kissei file law suits against Sandoz and Hetero over Rapaflo patent
  • Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
  • FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
  • Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
  • US Supreme Court says patent settlement can "sometimes" be illegal
  • Actavis and Kissei file law suits against Sandoz and Hetero over Rapaflo patent

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS